Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix
University of Alabama at Birmingham · NCT07613047
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–85 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 70
- US sites recruiting
- 1
- Study start
- September 10, 2026
- Record last updated
- October 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This investigator-initiated study will compare ADM and resorbable cross-linked collagen membrane barriers for guided bone regeneration at atrophic lateral ridge augmentation sites.
Being studied: Guided Bone Regeneration with ADM (AlloDerm) as a barrier; Guided Bone Regeneration with Resorbable Crosslinked Collagen Matrix (Mem-Lok) as a barrier
Conditions: Acellular Dermal Matrix; Bone Grafting; Soft Tissue Grafting
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- English speaking
- At least 18 years old
- Must be a patient of the UAB Dental School
- Able to read and understand informed consent document
- Patients presenting with a diagnosed need horizontal ridge augmentation with GBR without simultaneous implant placement, to allow for future dental implant placement.
- Presence of periodontally healthy, non-carious neighboring teeth and/or healthy restored dental implants on either side of the edentulous span planned for GBR, or unhealthy adjacent teeth to be extracted during the same visit.
- ≤4 mm ridge width in a Seibert Class I Edentulous span19
- No anticipated need for surgical and/or endodontic care at planned teeth adjacent to the proposed surgical site during the study period.
Exclusion Criteria
- Non-English speaking
- Less than 18 years old
- Smokers/nicotine users (defined as currently reporting use of any form of tobacco/nicotine products)
- Patients with systemic pathologies or conditions contraindicating oral surgical procedures or adversely affecting wound healing, including:
- Uncontrolled diabetes (HbA1c > 7%)
- Untreated periodontal disease
- History of head/neck radiation
- IV bisphosphonates
- Immunocompromised state
- Pregnancy
- Acute infection at site
- Documented or suspected allergy or sensitivity to any study product
Recruiting US locations
University of Alabama at Birmingham
Birmingham, AL 35294
Site contact: Maria Geisinger, DDS, MS · 205-934-4984 · miagdds@uab.edu
Study contacts (from the official record)
- Maria Geisinger, DDS, MS · 205-934-4984 · miagdds@uab.edu
- Sarah Startley, DMD · 205-975-8711 · ss1971@uab.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65